An Introduction to Oncology based Pharmacogenetics
03 Aug 2010
On 9 December 2010 at The Nowgen Centre
This is a new one-day course which Nowgen is delivering in partnership with Dr William Newman from Central Manchester University Hospitals NHS Foundation Trust & British Oncology Pharmacy Association (BOPA).
Contributors to the course will include:
- Dr William Newman
- Leading experts from AstraZeneca
- Dr Katherine Payne, The University of Manchester
- Leading clinicians from the Christie Hospital
The course will cover:
- An introduction to pharmacogenetics
- Contribution of pharmacogenetics to target identification; drug development; safety monitoring and optimisation of therapy
- Impact of pharmacogenetics on clinical trials, size and regulatory approval
- Ethical issues for patients and investigators involved in pharmacogenetics clinical trials
- Health economic perspectives of pharmacogenetics
- Case studies of pharmacogenetic testing
- Considerations for sources of tissue or sample collection for diagnostic purposes
- Pharmacogenetic diagnostic testing in the NHS
For full details and booking information, please visit: